Authors: ELKINDHIRSCH KE ANANIA C MALINAK R

Citation: Ke. Elkindhirsch et al., ORAL-CONTRACEPTIVE THERAPY FOR POLYCYSTIC OVARY DISEASE AFTER CHRONICGONADOTROPIN-RELEASING AGONIST ADMINISTRATION - PREDICTORS OF CONTINUED OVARIAN SUPPRESSION, Journal of reproductive medicine, 41(9), 1996, pp. 645-652

Authors: RUCHHOFT EA ELKINDHIRSCH KE MALINAK R

Citation: Ea. Ruchhoft et al., PITUITARY-FUNCTION IS ALTERED DURING THE SAME CYCLE IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME TREATED WITH CONTINUOUS OR CYCLIC ORAL-CONTRACEPTIVES OR A GONADOTROPIN-RELEASING-HORMONE AGONIST, Fertility and sterility, 66(1), 1996, pp. 54-60

Authors: ELKINDHIRSCH KE ANANIA C MACK M MALINAK R

Citation: Ke. Elkindhirsch et al., COMBINATION GONADOTROPIN-RELEASING-HORMONE AGONIST AND ORAL-CONTRACEPTIVE THERAPY IMPROVES TREATMENT OF HIRSUTE WOMEN WITH OVARIAN HYPERANDROGENISM, Fertility and sterility, 63(5), 1995, pp. 970-978